These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3926447)

  • 41. [Intermittent claudication: review of a disease of growing prevalence. II. Treatment].
    Riambau V; Piñol C
    Med Clin (Barc); 1998 Feb; 110(6):220-7. PubMed ID: 9580403
    [No Abstract]   [Full Text] [Related]  

  • 42. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution].
    Visconti W; Grillo N
    Minerva Med; 1985 May; 76(19-20):945-53. PubMed ID: 3158842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diagnosis and therapy of Raynaud's phenomenon (author's transl)].
    Goebel KM; Neitzert A
    Ther Umsch; 1975 Jun; 32(6):350-6. PubMed ID: 806127
    [No Abstract]   [Full Text] [Related]  

  • 44. [Flunarizine in the therapy of chronic cerebrovascular insufficiency. Multicentric controlled study].
    Arrigo A; Lottici P; Alfonsi E; Terraneo GB
    Clin Ter; 1984 Sep; 110(6):541-8. PubMed ID: 6238768
    [No Abstract]   [Full Text] [Related]  

  • 45. [Drug therapy of intermittent claudication in the IIb stage of arterial occlusive disease].
    Kriessmann A; Neiss A; Lutilsky L; Beermann M; Kramann B
    Med Welt; 1979 Jun; 30(23):888-91. PubMed ID: 459805
    [No Abstract]   [Full Text] [Related]  

  • 46. Multicriteria decision analysis for determining drug therapy for intermittent claudication.
    Pérez Encinas M; Fernández MA; Martín ML; Calvo MV; Gómez-Alonso A; Dominguez-Gil A; Lozano F
    Methods Find Exp Clin Pharmacol; 1998 Jun; 20(5):425-31. PubMed ID: 9701781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evidence-based therapy of intermittent claudication].
    Krankenpfl J; 2004; 42(5-6):184. PubMed ID: 15527244
    [No Abstract]   [Full Text] [Related]  

  • 48. 'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.
    Spagnoli A; Tognoni G
    Drugs; 1983 Jul; 26(1):44-69. PubMed ID: 6349963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [On the treatment of acute arterial circulatory disturbances of the retina and optic nerve (author's transl)].
    Küchle HJ
    Klin Monbl Augenheilkd; 1977 Sep; 171(3):395-406. PubMed ID: 336975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Naftidrofuryl in arterial obstructive disease: A systematic revue of the literature].
    Bourrion B; Hazard A; Baltazard H; Sebbag P; Fournier L; François M
    Rev Med Interne; 2020 Feb; 41(2):89-97. PubMed ID: 31669163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of a combination of raubasine, dihydroergocristine and dihydroergotamine in dogs and human beings.
    Marzo A; Ghirardi P; Parenti MA; Merlo L; Marchetti G; Cavalca L; Omboni E; Pignataro T; Ligresti A
    Farmaco Prat; 1981 Apr; 36(4):173-97. PubMed ID: 6785104
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical studies in peripheral arterial occlusive disease: update from the aspects of a meta-narrative review].
    Melzer J; Saller R
    Forsch Komplementmed; 2013; 20 Suppl 2():17-21. PubMed ID: 23860108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
    Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].
    Horsch S; Claeys L
    Vasa Suppl; 1992; 35():151-2. PubMed ID: 1481024
    [No Abstract]   [Full Text] [Related]  

  • 55. Brain hypoxia in migraine: pathophysiologic and therapeutic implications.
    Amery WK
    J Cereb Blood Flow Metab; 1982; 2 Suppl 1():S62-5. PubMed ID: 7045147
    [No Abstract]   [Full Text] [Related]  

  • 56. [Double-blind study on piribedil in peripheral arterial diseases].
    Milliken JC; Fares CM; O'Connor D
    Minerva Med; 1976 May; 67(25):1662-7. PubMed ID: 778668
    [No Abstract]   [Full Text] [Related]  

  • 57. [Intravenous infusions in the treatment of arterial occlusive diseases from the surgical point of view].
    Hugeneck J
    Wien Med Wochenschr; 1976 Sep; 126(38):542-4. PubMed ID: 788353
    [No Abstract]   [Full Text] [Related]  

  • 58. [Peripheral arterial occlusions. Principles, possibilities and limits of conservative therapy].
    Heidrich H
    ZFA (Stuttgart); 1981 Apr; 57(10):742-50. PubMed ID: 6165157
    [No Abstract]   [Full Text] [Related]  

  • 59. [Secondary prevention and conservative therapy of obliterative arteriosclerosis].
    Landi A
    Orv Hetil; 2004 May; 145(20):1035-43. PubMed ID: 15202325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease.
    Trübestein G; Trübestein R; Duong QD
    Angiology; 1981 Oct; 32(10):705-10. PubMed ID: 7034591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.